Hosted by Megan Maroney, PharmD, BCPP, FAAPP, Psychiatric Pharmacy Pulse will examine therapies, trends, and clinical decisions shaping care for psychiatric conditions, as well as cover new drug approvals and key data from notable conferences and trials. Through conversations with experts, the show will bridge the gap between clinical evidence and real-world practice. Psychiatric Pharmacy Pulse is a resource for pharmacists and other health care professionals who want to stay current in the fast-moving field of psychiatry.
As centanafadine awaits DEA scheduling, Megan Maroney, PharmD, BCPP, FAAPP, and Danielle Stutzman, PharmD, BCPP, unpack what its modest efficacy data, favorable interaction profile, and pediatric dosing considerations mean for real-world ADHD prescribing.
Maroney and her guest, Danielle Stutzman, PharmD, BCPP, break down efficacy data and potential advantages of centanafadine, the newly approved triple reuptake inhibitor for ADHD.
The podcast will cover relevant areas in psychiatry, new literature and clinical data, new drugs, and other topics that are coming down the pipeline.
In this new show, host Megan Maroney, PharmD, BCPP, FAAPP, will examine therapies, trends, and clinical decisions shaping care for psychiatric conditions.
